Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2007

01-10-2007 | Breast Oncology

Intraoperative Touch Preparation Cytology for Margin Assessment in Breast-Conservation Surgery: Does It Work for Lobular Carcinoma?

Authors: Edna K. Valdes, MD, Susan K. Boolbol, MD, Irfan Ali, MD, Sheldon M. Feldman, MD, Jean-Marc Cohen, MD

Published in: Annals of Surgical Oncology | Issue 10/2007

Login to get access

Abstract

Background

Breast carcinoma is the most frequently diagnosed malignancy in women of the North America. The combination of breast-conservation surgery and radiotherapy has become a standard of treatment for most breast cancers. It is critical to obtain clear margins to minimize local recurrence. The literature suggests that intraoperative touch preparation cytology (IOTPC) can be useful in evaluation of margins. Invasive lobular carcinoma (ILC) accounts for 10% to 15% of all breast cancers. Obtaining clear margins in ILC can be more challenging. Literature shows the positive margin rate for ILC to be as high as 60%. This report describes our experience with IOTPC for margin assessment in ILC by a single surgeon at Beth Israel Medical Center. The purpose of this study is to determine whether IOTPC is reliable for ILC.

Methods

A prospective review of 73 patients who underwent breast-conservation surgery with the use of IOTPC for margin assessment at Beth Israel Medical Center was performed. Pathology revealed ILC in 12 of these patients (16.4%), who are the subjects of this study. The lumpectomy specimens were oriented by the surgeon intraoperatively and were submitted fresh to pathology for cytologic assessment. IOTPC consisted of touching the corresponding margin onto the glass slide. The principle of this technique is that if cancer cells are present, they will stick to the slide, whereas fat cells will not. Six slides were prepared for each lumpectomy specimen. Air-dried samples were stained immediately by the Diff-Quik method and examined under the microscope by a cytopathologist.

Results

Twelve patients with ILC underwent breast-conservation surgery with IOTPC for assessment of 72 margins. Ten patients had lobular carcinoma only, and the remaining two patients had a combination of lobular and ductal carcinoma. There was a correlation between IOTPC and final pathology in 60 of 72 margins, which accounted for 83.3% of the cases. IOTPC for assessment of margins in patients undergoing breast-conservation surgery for ILC has a sensitivity of 8.3%, specificity of 98.3%, positive predictive value of 50%, and negative predictive value of 84.3%.

Conclusions

On the basis of our experience, IOTPC is of limited value for intraoperative assessment of margins for ILC.
Literature
1.
Singletary SE. Surgical margins in patients with early-stage breast cancer with breast conservation surgery. Am J Surg 2002;184:383–93PubMedCrossRef
2.
Pierce LJ, Strawderman MH, Douglas KR, Lichter AS. Conservative surgery and radiotherapy for early-stage breast cancer using a lung density correction: the University of Michigan experience. Int J Radiat Oncol Biol Phys 1997;39:921–8PubMedCrossRef
3.
Creager AJ, Shaw JA, Young PR, Geisinger KR. Intraoperative evaluation of lumpectomy margins by imprint cytology with histologic correlation. Arch Pathol Lab Med 2002;126:846–8PubMed
4.
Cox CE, Hyacinthe M, Gonzalez R, et al. Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome. Ann Surg Oncol 1997;4:644–9PubMedCrossRef
5.
Klimberg VS, Westbrook KC, Korourian S. Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol 1998;5:220–6PubMedCrossRef
6.
Heimann R, Powers C, Halpern HJ, et al. Breast preservation in stage I and II carcinoma of the breast. Cancer 1996;78:1722–30PubMedCrossRef
7.
Clarke DH, Le MG, Sarrazin D, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985;11:137–45PubMed
8.
Dibiase SJ, Komarnicky LT, Schwartz GF, Xie Y, Mansfield CM. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998;82:2212–20PubMedCrossRef
9.
10.
Dongen JAV, Bartelink H, Fentiman IS, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC Trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992;28:801–5CrossRef
11.
Burke MF, Allison R, tripcony L. Conservative therapy of breast cancer in Queensland. Int J Radiat Oncol Biol Phys 1995;31:295–303PubMedCrossRef
12.
Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989;17:719–25PubMed
13.
Mansfield CM, Komarnicky LT, Schwartz GF, et al. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 1995;75:2328–36PubMedCrossRef
14.
Slotman BJ, Meyer OWM, Njo KH, Karim ABMF. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol 1994;30:206–12PubMedCrossRef
15.
Leborgne F, Leborgne JH, Ortega B, Doldan R, Zubizarreta E. Breast conservation treatment of early stage breast cancer: patterns of failure. Int J Radiat Oncol Biol Phys 1995;31:765–75PubMedCrossRef
16.
Cox CE, Pendas S, Ku NNK, Reintgen DS, Greenberg HS, Nicosia SV. Local recurrence of breast cancer after cytological evaluation of lumpectomy margins. Am Surg 1998;64:533–8PubMed
17.
Saarela AO, Paloneva TK, Rissanen TJ, Kiviniemi HO. Determinants of positive histologic margins and residual tumor after lumpectomy foe early breast cancer: a prospective study with special reference to touch preparation cytology. J Surg Oncol 1997;66:248–53PubMedCrossRef
18.
Borger J, Kemperman H, Hart A, Peterse H, Dongen JV, Bartelink H. Risk factors in breast-conservation therapy. J Clin Oncol 1194;12:653–60
19.
20.
Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994;74:1746–51PubMedCrossRef
21.
Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995;76:259–67PubMedCrossRef
22.
Ku KNN, Cox CE, Reintgen DS, Greenberg HM, Nicosia SV. Cytology of lumpectomy specimens. Acta Cytol 1991;35:417–21PubMed
23.
Henry-Tillman RS, Korourian S, Rubio IT, et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol 2002;9:333–9PubMedCrossRef
24.
Cox CE, Ku NN, Reintgen DS, Greenberg HM, Nicosia SV, Wangensteen S. Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg 1991;126:490–3PubMed
25.
Karamlou T, Johnson NM, Chan B, Franzini D, Mahin D. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg 2003;185:425–8PubMedCrossRef
26.
Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6:149–56CrossRef
27.
Francis A, England DW, Rowlands DC, Wadley M, Walker C, Bradley SA. The diagnosis of invasive lobular breast carcinoma. Does MRI have a role? Breast 2001;10:38–40PubMedCrossRef
28.
Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg S. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 1998;5:689–94PubMedCrossRef
29.
Mullenix PS, Carter PL, Martin MJ, et al. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Am J Surg 2003;185:420–4PubMedCrossRef
30.
Menes TS, Tartter PI, Mizrachi H, Rosenbaum-Smith S, Estabrook A. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol 2003;10:1166–70PubMedCrossRef
31.
Gal R. Scrape cytology assessment of margins of lumpectomy specimens in breast cancer. Acta Cytol 1988;32:838–9PubMed
32.
Shaw EH, Eng MROS, Lond LROP. The immediate microscopic diagnosis of tumours at the time of operation. Lancet 1910;939–42
33.
Takehara M, Tamura M, Kameda H, Ogita M. Examination of breast conserving therapy in lobular carcinoma. Breast Cancer 2004;11:69–72PubMedCrossRef
Metadata
Title
Intraoperative Touch Preparation Cytology for Margin Assessment in Breast-Conservation Surgery: Does It Work for Lobular Carcinoma?
Authors
Edna K. Valdes, MD
Susan K. Boolbol, MD
Irfan Ali, MD
Sheldon M. Feldman, MD
Jean-Marc Cohen, MD
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9364-1

Other articles of this Issue 10/2007

Annals of Surgical Oncology 10/2007 Go to the issue

Breast Oncology

Sentinel Lymph Node Biopsy Performed After Neoadjuvant Chemotherapy is Accurate in Patients with Documented Node-Positive Breast Cancer at Presentation

Laboratory Research

Targeting of Insulin-like Growth Factor-I Receptor with a Monoclonal Antibody Inhibits Growth of Hepatic Metastases from Human Colon Carcinoma in Mice

Breast Oncology

Breast Papillomas in the Era of Percutaneous Needle Biopsy

Hepatic and Pancreatic Tumors

Long Term Outcome and Prognostic Factors for Large Hepatocellular Carcinoma (10 cm or more) after Surgical Resection

Endocrine Tumors

Anaplastic Carcinoma of the Thyroid Arising More Often from Follicular Carcinoma than Papillary Carcinoma

Breast Oncology

Clinicopathologic Features and Long-Term Outcomes of 293 Phyllodes Tumors of the Breast